Ọgwụ "Tavanic". ntụziaka

Tavanik (analọg - elefoks ma ọ bụ floratsid) mejupụtara a akụkụ nke levofloxacin. The ọgwụ dị na mbadamba ụdị, dị ka a ngwọta maka infusion. Tavanic ndu kọwara dị ka a sịntetik antibacterial gị n'ụlọnga na a iche iche sara mbara nke mmetụta. Ọgwụ bụ fluoroquinolones otu.

Ịgbaso onu (onu) ngwa nke levofloxacin fọrọ kpamkpam na ngwa ngwa etinye obi gị dum. Jiri nke nri nwere obere mmetụta na ihe zuru ezu na ọnụego nke absorption. Akụrụngwa penetrates nsụkọrọ na akụkụ (akpa ume, sputum, bronchial mucosa, ọkpụkpụ, prostate, spinal ọmụmụ , wdg) nnọọ nke ọma.

Minor ichekwa-arụ ọrụ bekee dezatsitiliruetsya ma ọ bụ oxidized. Excretion na-advantageously rụrụ site na akụrụ ya. N'elu nnata nke mbadamba ụdị ọgwụ maka iri anọ na asatọ awa anyụpụ na mmamịrị banyere 87% nke onunu ogwu nakweere agbanweghi agbanwe. Mgbe iri asaa na abụọ awa na nsị ahụrụ bụ ihe na-erughị 4%. Mgbe igba ogwu n'akwara ochichi excretion emee karịsịa na mmamịrị na-agbanweghi agbanwe ụdị.

Levofloxacin bụ ọrụ megide kasị microorganisms (anaerobic, gram-nti, gram-adịghị mma).

Tavanic ntụziaka anaghị nwere ike ikwu na ojiji nke-eto eto na ụmụ n'ihi na ihe ize ndụ nke mmepe nke cartilage ọnya na nkwonkwo. N'ịhọpụta ọgwụ ọrịa na ndị agadi ga-gaa na akaụntụ likelihood nke ọnụnọ nke ọrịa nke gbasara akụrụ ọrụ.

Tavanik nwere ike enweghi ezigbo ọgwụgwọ nrụpụta na oyi baa elu ogo ike ndọda, mere site pneumococcus. Nchikota ọgwụ nwere ike a chọrọ maka ọgwụ na-efe efe, iwe na ụfọdụ pathogens.

Ọrịa ndị na-na mbụ nwere ụbụrụ mmebi jikọtara oké trauma ma ọ bụ ọrịa strok, tavanic nwere ike kpasuo ọgụ nke ụfụ. The puru nke ụfụ na-amụba site concomitant ojiji nke fenbufen na yiri ya NSAIDs (ndị so ná ndị mgbochi mkpali ọgwụ ọjọọ) ma ọ bụ theophylline.

Iji ọgwụ nwere ike ime ka nkụnwụ, dizziness, visual disturbances. Tavanic na mmanya jikọtara akpasu mmepe nke ndị a oghom Jeremaya mere ka a ukwuu.

Anya ndinọ ka ọrịa na erughi nke glucose-6-phosphate dehydrogenase.

Tavanic. Ntuziaka: àmà

The nkwadebe na-kenyere obodo-enwetara oyi baa, prostatitis, na-efe efe mgbagwoju anya urinary tract na akụrụ (gụnyere pyelonephritis), intra-abdominal na-efe efe, bacteremia (septicemia) jikọtara kwuru pathologies.

Tavanic. Ntuziaka: contraindications

Ọ bụghị kenyere ọgwụ n'oge ime, àkwụkwụ, ọnya nke akwara n'oge ọgwụgwọ na quinolones n'akụkọ ihe mere eme, ụmụ n'okpuru iri na asatọ afọ, lactation, ọgwụ intolerance Efrata.

The na-atụ aro usoro onunu ogwu (intravenously ma ọ bụ ọnụ) - otu a ụbọchị ma ọ bụ ugboro abụọ 250-500 milligrams. Kpọmkwem ego nke ọgwụ kpebisiri ike site ịga dibịa-ewere n'ime akaụntụ susceptibility na ogo nke na-efe efe ọnya.

Ovadozu egosipụta ọgụ nke ọdịdọ na ndabere nke akwụkwụ ọdịdọ, delirium, erosive ọnya nke mucous membranes, ọgbụgbọ. Levofloxacin egosighi site dialysis. Mgbe overdosing gosiri symptomatic ọgwụ.

Mmetụta ọjọọ na-ezighị ezi eji otu extra tavanic mbadamba (250 mg) e nyere.

Mgbe mpụta ìhè nke oghom mmetụta dị mkpa na-ahụ a ọkachamara.